CURIS, INC. Severance Costs
CURIS, INC. (CRIS) reported Severance Costs of $300.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2020-03-19
- CURIS, INC. severance costs for the quarter ending 2018-12-31 was $0.00.
- CURIS, INC. severance costs for the quarter ending 2018-09-30 was $300.00K.
- CURIS, INC. severance costs for fiscal 2019 was $300.00K.
| Period end | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|---|
| 2019-12-31 | $300.00K 10-K · filed 2020-03-19 | |||
| 2018-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2019-11-05 | $300.00K derived: sum of 2 quarters · filed 2019-11-05 | $300.00K 10-Q · filed 2019-11-05 | |
| 2018-09-30 | $300.00K 10-Q · filed 2018-11-01 | $300.00K 10-Q · filed 2018-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |